What's in Bio Genuine (Shanghai) Biotech Co., Ltd.'s pipeline?

Bio Genuine (Shanghai) Biotech Co., Ltd. has 4 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Bio Genuine (Shanghai) Biotech Co., Ltd.'s portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bio-genuine-shanghai-biotech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Bio Genuine (Shanghai) Biotech Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bio Genuine (Shanghai) Biotech Co., Ltd. pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Add-back therapy	Add-back therapy	phase 3	Hormone replacement therapy / Adjunctive hormonal therapy		Gynecology / Endometriosis / Uterine Fibroids
BG2109	BG2109	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Placebo for add-back therapy	Placebo for add-back therapy	phase 3			Endocrinology
Placebo for BG2109	Placebo for BG2109	phase 3

Therapeutic area mix

Diabetes · 1
Endocrinology · 1
Gynecology / Endometriosis / Uterine Fibroids · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bio Genuine (Shanghai) Biotech Co., Ltd.:

Cite this brief

Drug Landscape (2026). Bio Genuine (Shanghai) Biotech Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bio-genuine-shanghai-biotech-co-ltd. Accessed 2026-05-18.